Evidence map›Paper›PMID 26733965›Full record

ReviewFrontiers in microbiology2015

Potential Use of Phenolic Acids as Anti-Candida Agents: A Review.

Guilherme R Teodoro, Kassapa Ellepola, Chaminda J Seneviratne, Cristiane Y Koga-Ito

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed.

  1. Article
  2. Organ-Specific Distribution of Bioactive Compounds inAntioxidants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Natural product based approaches to overcomeFrontiers in antibiotics · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guilherme R TeodoroOral Biopathology Graduate Program, São José dos Campos Institute of Science and Technology, Universidade Estadual Paulista São José dos Campos, Brazil.
Kassapa EllepolaOral Sciences, Faculty of Dentistry, National University of Singapore Singapore, Singapore.
Chaminda J SeneviratneOral Sciences, Faculty of Dentistry, National University of Singapore Singapore, Singapore.
Cristiane Y Koga-ItoOral Biopathology Graduate Program, São José dos Campos Institute of Science and Technology, Universidade Estadual PaulistaSão José dos Campos, Brazil; Department of Environmental Engineering and Biopathology Graduate Program, São José dos Campos Institute of Science and Technology, Universidade Estadual PaulistaSão José dos Campos, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been a sharp rise in the occurrence of Candida infections and associated mortality over the last few years, due to the growing body of immunocompromised population. Limited number of currently available antifungal agents, undesirable side effects and toxicity, as well as emergence of resistant strains pose a considerable clinical challenge for the treatment of candidiasis. Therefore, molecules that derived from natural sources exhibiting considerable antifungal properties are a promising source for the development of novel anti-candidal therapy. Phenolic compounds isolated from natural sources possess antifungal properties of interest. Particularly, phenolic acids have shown promising in vitro and in vivo activity against Candida species. However, studies on their mechanism of action alone or in synergism with known antifungals are still scarce. This review attempts to discuss the potential use, proposed mechanisms of action and limitations of the phenolic acids in anti-candidal therapy.

Indexed as

antifungal effectCandidaphenolic acidsphenolic compoundssynergism

Identifiers

PMID26733965
PMCPMC4685070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.